{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:27:13Z","timestamp":1788280033907,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.semarthrit.2024.152472","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T16:37:11Z","timestamp":1717432631000},"page":"152472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical management of lupus in the United States: A claims-based analysis"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9923-4709","authenticated-orcid":false,"given":"Kathryn M.","family":"Kingsmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Zent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152472_bib0001","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1191\/9612332lu155oa","article-title":"Baseline characteristics of a multiethnic lupus cohort: PROFILE","volume":"11","author":"Alarc\u00f3n","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0002","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.30187","article-title":"Network analysis of associations between serum interferon-\u03b1 activity, autoantibodies, and clinical features in systemic lupus erythematosus","volume":"63","author":"Weckerle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0003","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.1780220304","article-title":"Anti-dsdna and complement profiles as prognostic guides in systemic lupus erythematosus","volume":"22","author":"Swaak","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0004","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#","article-title":"American college of rheumatology Ad Hoc committee on systemic lupus erythematosus guidelines - PubMed","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0005","article-title":"The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus Ettore Sabadini Azienda Ospedaliera Papa Giovanni XXIII","author":"Sinico","year":"2001","journal-title":"Article J Nephrol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0006","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.20980","article-title":"Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus","volume":"52","author":"Linnik","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0007","first-page":"S120","article-title":"Assessment of systemic lupus erythematosus","volume":"23","author":"Lam","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0008","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American college of rheumatology guidelines for screening, case definition, treatment and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0009","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1093\/rheumatology\/kex286","article-title":"The british society for rheumatology guideline for the management of systemic lupus erythematosus in adults","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0011","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0961203309356289","article-title":"Identification and validation of lupus nephritis cases using administrative data","volume":"19","author":"Chibnik","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0012","unstructured":"U.S. Bureau of Labor Statistics, Consumer price index for all urban consumers: medical care in U.S. City average [CPIMEDSL] n.d. https:\/\/fred.stlouisfed.org\/series\/cpimedsl (accessed 2023)."},{"key":"10.1016\/j.semarthrit.2024.152472_bib0013","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European league against rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0014","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0015","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.284.8.984","article-title":"Quality of care for patients with rheumatoid arthritis","volume":"284","author":"MacLean","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0016","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.1993.00410190069009","article-title":"Progression of functional disability in patients with rheumatoid arthritis: associations with rheumatology subspecialty care","volume":"153","author":"Ward","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0017","article-title":"Role of specialty care in the management of patients with systemic lupus erythematosus","volume":"29","author":"Urowitz","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0018","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/j.ajkd.2018.10.011","article-title":"Update on the native kidney biopsy: core curriculum 2019","volume":"73","author":"Luciano","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0019","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1136\/annrheumdis-2020-217017","article-title":"Do 2019 European league against rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?","volume":"81","author":"Teng","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005792-197103000-00001","article-title":"The natural history of systemic lupus erythematosus by prospective analysis","volume":"50","author":"Estes","year":"1971","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0021","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3899\/jrheum.170953","article-title":"Epidemiology and survival of systemic sclerosis-systemic lupus erythematosus overlap syndrome","volume":"45","author":"Alharbi","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0022","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3899\/jrheum.080091","article-title":"Systemic lupus erythematosus features in rheumatoid arthritis and their impact on overall mortality","volume":"36","author":"Icen","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/OARRR.S167783","article-title":"Sj\u00f6gren's syndrome and systemic lupus erythematosus: links and risks","volume":"11","author":"Pasoto","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000084","article-title":"Patients with overlap autoimmune disease differ from those with \u2018pure\u2019 disease","volume":"2","author":"Lockshin","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3899\/jrheum.081067","article-title":"Overlap between systemic lupus erythematosus and rheumatoid arthritis: is it real or just an illusion?","volume":"36","author":"Amezcua-Guerra","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0026","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ajkd.2010.12.026","article-title":"Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community","volume":"58","author":"White","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0027","article-title":"Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis","volume":"35","author":"Siedner","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0028","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.rdc.2014.04.004","article-title":"The kidney biopsy in lupus nephritis: is it still relevant?","volume":"40","author":"Rovin","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0029","first-page":"565","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat Rev Rheumatol 2020 16:10"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0030","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A","article-title":"A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus","volume":"44","author":"Ho","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0031","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8","article-title":"Decreases in anti\u2013double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus","volume":"44","author":"Ho","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0032","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/rheumatology\/kem112","article-title":"Fifty years of anti-ds DNA antibodies: are we approaching journey's end?","volume":"46","author":"Isenberg","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0033","first-page":"2150","article-title":"Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. | The Journal of Rheumatology","volume":"32","author":"Vil\u00e1","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000435","article-title":"Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis","volume":"7","author":"Birt","year":"2020","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0035","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3899\/jrheum.220822","article-title":"Long-term opioid therapy among patients with systemic lupus erythematosus in the community: a lupus midwest network (LUMEN) Study","volume":"50","author":"Figueroa-Parra","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0036","doi-asserted-by":"crossref","first-page":"819","DOI":"10.15585\/mmwr.mm6838a2","article-title":"Prescription opioid use in patients with and without systemic lupus erythematosus - michigan lupus epidemiology and surveillance program, 2014-2015","volume":"68","author":"Somers","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0037","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/1529-0131(199804)41:4<725::AID-ART21>3.0.CO;2-Z","article-title":"Evaluative laboratory testing practices of United States rheumatologists","volume":"41","author":"Donald","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0038","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/acr.23569","article-title":"Does systemic lupus erythematosus care provided in a lupus clinic result in higher quality of care than that provided in a general rheumatology clinic?","volume":"70","author":"Arora","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0039","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10067-017-3713-7","article-title":"Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics","volume":"36","author":"Aljohani","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0040","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.11467","article-title":"Participatory patient\u2013physician communication and morbidity in patients with systemic lupus erythematosus","volume":"49","author":"Ward","year":"2003","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0041","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.clinthera.2009.11.032","article-title":"Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database","volume":"31","author":"Pelletier","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0042","doi-asserted-by":"crossref","first-page":"K62","DOI":"10.1016\/j.vaccine.2013.06.104","article-title":"A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data","volume":"31","author":"Moores","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0043","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3899\/jrheum.101149","article-title":"The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases","volume":"38","author":"Bernatsky","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0044","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pds.3319","article-title":"Validity of health plan and birth certificate data for pregnancy research","volume":"22","author":"Andrade","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0045","first-page":"2545","article-title":"Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus","volume":"29","author":"Costenbader","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0046","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3111\/13696998.2013.778270","article-title":"Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan","volume":"16","author":"Garris","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0047","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.3899\/jrheum.110571","article-title":"Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality","volume":"38","author":"Broder","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0048","first-page":"36","article-title":"Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United States","volume":"29","author":"Dall'Era","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3271","article-title":"Risk factors for ANA positivity in healthy persons","volume":"13","author":"Li","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0050","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/art.42330","article-title":"Increasing prevalence of antinuclear antibodies in the United States","volume":"74","author":"Dinse","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0051","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2006.09.001","article-title":"Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus","volume":"27","author":"Wandstrat","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.11590","article-title":"Disparities in lupus and the role of social determinants of health: current state of knowledge and directions for future research","author":"Buie","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0053","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/BOR.0b013e328323daad","article-title":"Disparities in lupus care and outcomes","volume":"21","author":"Demas","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0054","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/annrheumdis-2022-222276","article-title":"Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades","volume":"81","author":"Duarte-Garc\u00eda","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0055","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/art.42375","article-title":"Incidence, prevalence, and mortality of lupus nephritis: a population-based study over four decades using the lupus midwest network","volume":"75","author":"Hocao\u01e7lu","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0056","first-page":"2179","article-title":"Diagnosis of systemic lupus erythematosus","volume":"68","author":"Gill","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0057","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.mcna.2020.10.003","article-title":"Antinuclear antibody testing for the diagnosis of systemic lupus erythematosus","volume":"105","author":"Nashi","year":"2021","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0058","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pop.2018.02.002","article-title":"A primer on rheumatologic laboratory tests: what they mean and when to order them","volume":"45","author":"Patel","year":"2018","journal-title":"Prim Care"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0059","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/art.10558","article-title":"Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests","volume":"47","author":"Kavanaugh","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40258-014-0085-x","article-title":"Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes","volume":"12","author":"Oglesby","year":"2014","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.semarthrit.2024.152472_bib0061","doi-asserted-by":"crossref","unstructured":"Wallace D.J. Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox. 2008;17:91\u20132. https:\/\/doi.org\/10.1177\/0961203307086267.","DOI":"10.1177\/0961203307086267"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:13:28Z","timestamp":1726618408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":61,"alternative-id":["S0049017224001124"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152472","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical management of lupus in the United States: A claims-based analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152472"}}